Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -50.72%68K | -33.90%117K | 26.98%560K | 138K | 53.91%177K | 145.00%441K | ||||
| Gross profit | 50.72%-68K | 33.90%-117K | -26.98%-560K | -138K | -53.91%-177K | -145.00%-441K | ||||
| Operating expense | 1.10%7.89M | 52.11%10.41M | 20.32%10.03M | -37.91%31.4M | -68.75%8.1M | 8.69%7.81M | -33.95%6.85M | 19.15%8.34M | 146.77%50.57M | 202.00%25.92M |
| Selling and administrative expenses | 10.31%6.54M | 100.88%8.21M | 56.52%8.22M | -27.37%21.32M | -59.64%6.06M | 12.95%5.92M | 1.19%4.09M | 4.58%5.25M | 86.28%29.36M | 120.10%15.01M |
| -General and administrative expense | 10.31%6.54M | 100.88%8.21M | 56.52%8.22M | -27.37%21.32M | -59.64%6.06M | 12.95%5.92M | 1.19%4.09M | 4.58%5.25M | 86.28%29.36M | 120.10%15.01M |
| Depreciation amortization depletion | -37.70%76K | ---- | ---- | ---- | ---- | 22.00%122K | 40.82%138K | ---- | ---- | ---- |
| -Depreciation and amortization | -37.70%76K | ---- | ---- | ---- | ---- | 22.00%122K | 40.82%138K | ---- | ---- | ---- |
| Other operating expenses | -27.20%1.28M | -20.25%2.2M | -41.30%1.81M | -52.49%10.08M | -77.92%2.48M | -4.19%1.76M | -55.72%2.76M | 56.20%3.09M | 348.21%21.21M | 491.87%11.22M |
| Operating profit | -1.10%-7.89M | -50.08%-10.48M | -19.19%-10.15M | 37.35%-31.96M | 67.15%-8.66M | -8.69%-7.81M | 32.62%-6.98M | -19.72%-8.51M | -146.75%-51.01M | -200.83%-26.36M |
| Net non-operating interest income (expenses) | -30.00%4.78M | 13.05%7.08M | 14.72%7.12M | -11.88%26.61M | 34.49%7.32M | -25.50%6.82M | -38.11%6.26M | 13.29%6.2M | 582.42%30.2M | 55.39%5.45M |
| Non-operating interest income | -2.32%12.73M | 16.59%14.3M | 18.58%13.52M | -3.14%50.62M | 23.98%13.91M | -11.48%13.03M | -21.39%12.27M | 6.52%11.41M | 111.42%52.26M | 28.77%11.22M |
| Non-operating interest expense | 11.09%7.09M | 10.98%6.85M | 9.77%6.58M | 11.10%25.13M | 10.89%6.58M | 10.87%6.38M | 10.76%6.18M | 11.93%6M | 8.60%22.62M | 10.57%5.93M |
| Total other finance cost | 595.40%862K | 315.79%369K | 77.99%-175K | -100.35%-1.13M | 106.37%10K | 10.31%-174K | -94.32%-171K | -530.95%-795K | -4.64%-564K | -0.64%-157K |
| Other net income (expenses) | -4,337.15%-63.19M | 91.12%-697K | 70.28%-2.31M | -141.89%-20.55M | -111.43%-3.49M | -129.40%-1.42M | -151.76%-7.85M | -423.40%-7.78M | 401.37%49.06M | -11.84%30.53M |
| Gain on sale of security | -2,414.86%-9.82M | -99.76%17K | -93.76%326K | -65.02%14.68M | -85.44%1.81M | -94.65%424K | -61.34%7.22M | 79.82%5.22M | -12.59%41.96M | -66.82%12.46M |
| Special income (charges) | -6.58%-858K | 56.05%-225K | -111.98%-2.16M | 17.08%-6.99M | -38.71%-4.93M | 35.13%-805K | 72.01%-512K | 43.76%-1.02M | -141.44%-8.44M | ---3.56M |
| -Less:Restructuring and mergern&acquisition | 6.58%858K | -56.05%225K | 180.29%2.09M | -9.92%6.82M | 76.83%4.76M | -35.13%805K | -72.01%512K | -58.78%746K | --7.57M | --2.69M |
| -Gain on sale of business | ---- | ---- | 75.37%-67K | 79.68%-176K | ---- | ---- | ---- | ---272K | ---866K | ---- |
| Income before tax | -2,654.51%-66.3M | 52.19%-4.1M | 47.06%-5.34M | -191.71%-25.9M | -150.17%-4.82M | -135.29%-2.41M | -157.46%-8.58M | -223.25%-10.09M | 186.82%28.24M | -67.26%9.62M |
| Income tax | -1.83M | 0 | 1,907.69%1.83M | -200.00%-10.66M | 0 | 0 | -10.75M | 91K | 10.66M | 10.66M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -2,578.60%-64.47M | -288.51%-4.1M | 29.59%-7.17M | -101.18%-15.24M | -100.38%-4.82M | -136.35%-2.41M | -91.57%2.18M | -59.13%-10.18M | 1,476.93%1.29B | 12,376.15%1.26B |
| Net income continuous operations | -2,578.60%-64.47M | -288.51%-4.1M | 29.59%-7.17M | -186.68%-15.24M | -362.51%-4.82M | -135.29%-2.41M | -85.43%2.18M | -226.17%-10.18M | 154.05%17.58M | -103.55%-1.04M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 2,181.86%1.27B | 6,661.99%1.26B |
| Noncontrolling interests | -6,500.00%-66K | -11K | 44K | -6K | -5K | -1K | 0 | 0 | 0 | |
| Net income attributable to the company | -2,576.97%-64.41M | -288.00%-4.09M | 29.16%-7.21M | -101.18%-15.23M | -100.38%-4.82M | -136.34%-2.41M | -91.57%2.18M | -59.13%-10.18M | 1,476.93%1.29B | 12,376.15%1.26B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -2,576.97%-64.41M | -288.00%-4.09M | 29.16%-7.21M | -101.18%-15.23M | -100.38%-4.82M | -136.34%-2.41M | -91.57%2.18M | -59.13%-10.18M | 1,476.93%1.29B | 12,376.15%1.26B |
| Diluted earnings per share | -3,900.00%-0.4 | -400.00%-0.03 | 33.33%-0.04 | -101.09%-0.09 | -100.37%-0.03 | -125.00%-0.01 | -93.75%0.01 | -50.00%-0.06 | 1,284.29%8.29 | 10,050.00%8.12 |
| Basic earnings per share | -3,900.00%-0.4 | -400.00%-0.03 | 33.33%-0.04 | -101.12%-0.09 | -100.38%-0.03 | -125.00%-0.01 | -93.75%0.01 | -50.00%-0.06 | 1,245.71%8.02 | 9,712.50%7.85 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.